4//SEC Filing
Meltz Mark A 4
Accession 0001415889-25-016729
CIK 0001806952other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:47 PM ET
Size
5.5 KB
Accession
0001415889-25-016729
Insider Transaction Report
Form 4
Meltz Mark A
General Counsel
Transactions
- Award
Option (right to buy)
2025-06-09+100,000→ 100,000 totalExercise: $12.47Exp: 2035-06-08→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the option shares will vest on June 9, 2026, with the remaining option shares to vest in equal monthly installments over the following thirty-six months, subject to the reporting person providing service through the applicable vesting date.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001771329
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:47 PM ET
- Size
- 5.5 KB